Isolation and Characterisation of neuroprotective Substances from Fungi and Cyanobacteria as potential Compounds for the Treatment of neurodegenerative Diseases
The NeurodegX project aims at the identification of novel drugs and mechanisms of action for the treatment of neurodegenerative diseases.
A consortium of biotechnologically, cell-biologically and biomedically oriented scientists from three universities (HS Kaiserslautern, JGU Mainz, TUKaiserslautern) is working on the identification, isolation
Eggert, S., Kins, S., Endres, K., Brigadski, T., Brothers in arms: proBDNF/BDNF and sAPPα/Aβ signaling and their common interplay with ADAM10, TrkB, p75NTR, sortilin, and sorLA in the progression of Alzheimer`s disease. Biol.Chem 2021 Oct 7;403(1):43-71. doi: 10.1515/hsz-2021-0330. Print 2022 Jan 26.PMID: 34619027 Review. Corresponding author
Wi
News
Neuroforum 2020 Forschungskolleg “NeurodegX”
Can we trust the gut? JP
Current publications
Schäfer K.-H., Christmann A., Gries M. Can we trust the gut? The role of the intenstine in neurodegeneration. The Journal of Physiology. 2020 July 24. http://dx.doi.org/10.1113/JP280336.
Manuela Gries, Anne Christmann, Steven Schulte, Maximilian W
